AGIC Capital completed the acquisition of a majority stake in ATEC Pharmatechnik from Hannover Finanz.

AGIC Capital, a European-Asian private equity company, completed the acquisition of a majority stake in ATEC Pharmatechnik, a machinery parts manufacturer, from Hannover Finanz, a private equity firm. Financial terms were not disclosed. "We are excited to partner with AGIC, a firm that shares our passion for providing our customers with safer aseptic transfer technologies, which are critical to the future of medicine. We look forward to expanding our critical role in pharmaceutical manufacturing and bioprocessing as we invest in our next phase of growth," Hans-Werner Mumm, ATEC CEO.